INHIBITION BY CYCLOSPORINE OF INSULIN SECRETION—A BETA CELL‐SPECIFIC ALTERATION OF ISLET TISSUE FUNCTION

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Transplantation

• Publication date

  1991-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00007890-199111000-00026PMID 1683035
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclosporine inhibition of insulin secretion: effect of tolbutamide and extracellular calcium concentration.

  1990cited by this paper
• Short-term effects of cyclosporine on secretagogue-induced insulin release by isolated islets.

  1990cited by this paper
• Synthesis-Secretion Coupling of Insulin: Effect of Cyclosporin

  1989cited by this paper
• The fate of meshed allograft skin in burned patients using cyclosporin immunosuppression.

  1989cited by this paper
• Comparison of three immunosuppressive protocols in cardiac transplantation.

  1989cited by this paper
• Results of Pancreas-Transplant Registry

  1989cited by this paper
• Adult kidney retransplantation: evolution of treatment and results over 25 years at the University of Minnesota.

  1989cited by this paper
• Suppression of insulin release by galanin and somatostatin is mediated by a G-protein. An effect involving repolarization and reduction in cytoplasmic free Ca2+ concentration.

  1989cited by this paper
• Effects of prolonged cyclosporine-A treatment on the morphology and function of rat adrenal cortex.

  1989cited by this paper
• Intracellular events responsible for the inhibition of insulin secretion by somatostatin.

  1989cited by this paper
• Additive inhibitory effect of cyclosporine and verapamil may occur through different mechanisms that may be dependent or independent of the slow calcium channel.

  1989cited by this paper
• Cyclosporin-induced inhibition of insulin release. Possible role of voltage-dependent calcium transport channels.

  1988cited by this paper
• Dissociation between intracellular calcium mobilization and insulin secretion in isolated rat islets of Langerhans

  1988cited by this paper
• The biphasic stimulation of insulin secretion by bombesin involves both cytosolic free calcium and protein kinase C.

  1988cited by this paper
• Mechanisms of action of cyclosporine: effect on cells of the immune system and on subcellular events in T cell activation.

  1988cited by this paper
• Characterization of the cyclic AMP-independent actions of somatostatin in GH cells. I. An increase in potassium conductance is responsible for both the hyperpolarization and the decrease in intracellular free calcium produced by somatostatin.

  1988cited by this paper
• Characterization of the cyclic AMP-independent actions of somatostatin in GH cells. II. An increase in potassium conductance initiates somatostatin-induced inhibition of prolactin secretion.

  1988cited by this paper
• Calcium-calmodulin stimulates inositol 1,4,5-trisphosphate kinase activity from insulin-secreting RINm5F cells.

  1987cited by this paper
• Potentiators of insulin secretion modulate Ca2+ sensitivity in rat pancreatic islets.

  1987cited by this paper
• Role of cyclosporin A in macromolecular synthesis of beta-cells.

  1987cited by this paper
• Fetal rat intestinal cells in monolayer culture: a new in vitro system to study the glucagon-like immunoreactive peptides.

  1987cited by this paper
• Interference by cyclosporine with the endocrine function of the canine pancreas.

  1987cited by this paper
• Cytosolic Free-Calcium Concentrations in Normal Pancreatic Islet Cells: Effect of Secretagogues and Somatostatin

  1987cited by this paper
• Induction, suppression and superinduction of lymphokine mRNA in T lymphocytes.

  1987cited by this paper
• Toxic effects of cyclosporine on the endocrine pancreas of Wistar rats.

  1986cited by this paper
• Cyclosporin. Mechanism of action: in vitro studies.

  1986cited by this paper
• Does the binding of cyclosporine to calmodulin result in immunosuppression?

  1986cited by this paper
• A guanine nucleotide-binding protein mediates the inhibition of voltage-dependent calcium current by somatostatin in a pituitary cell line.

  1986cited by this paper
• Cyclosporin-Induced Inhibition of Insulin Secretion in Isolated Rat Islets and HIT Cells

  1986cited by this paper
• Reversibility of the acute toxic effect of Cyclosporin A on pancreatic B cells of Wistar rats

  1986cited by this paper
• Somatostatin, an inhibitor of ACTH secretion, decreases cytosolic free calcium and voltage-dependent calcium current in a pituitary cell line

  1986cited by this paper
• Failure of canine islet allografts and autografts with cyclosporine.

  1985cited by this paper
• The effects of cyclosporin A on the immune system.

  1985cited by this paper
• Morphological and functional changes of pancreatic B cells in cyclosporin A-treated rats

  1984cited by this paper
• Somatostatin lowers the cytosolic free Ca2+ concentration in clonal rat pituitary cells (GH3 cells).

  1984cited by this paper
• Deterioration in glucose metabolism in pancreatic transplant recipients given cyclosporin.

  1983cited by this paper
• Stimulation of insulin release in the absence of extracellular calcium by isobutylmethylxanthine and its inhibition by somatostatin.

  1980cited by this paper
• Magnesium modulation of glucose-induced insulin secretion by the perfused rat pancreas.

  1977cited by this paper
• Does somatostatin inhibition of insulin secretion involve two mechanisms of action?

  1976cited by this paper
• Reversal of somatostatin inhibition of insulin secretion by calcium.

  1974cited by this paper
• Characterization of the effects of arginine and glucose on glucagon and insulin release from the perfused rat pancreas.

  1974cited by this paper
• Stimulation of glucagon secretion by epinephrine in man.

  1973cited by this paper
• Dynamics of insulin secretion by the perfused rat pancreas.

  1968cited by this paper
• An immunochemical assay of total extractable insulin in man.

  1960cited by this paper

• Nutritional management of kidney transplant recipient

  2025cites this paper
• Tweaking Mesenchymal Stem/Progenitor Cell Immunomodulatory Properties with Viral Vectors Delivering Cytokines

  2016cites this paper
• Nutrition in Kidney Transplantation

  2013cites this paper
• Effect of Immunosuppressive Agents on Long-Term Survival of Renal Transplant Recipients

  2012cites this paper
• Improving the efficacy of type 1 diabetes therapy by transplantation of immunoisolated insulin-producing cells

  2011cites this paper
• Islet Transplantation a Decade Later and Strategies for Filling a Half-Full Glass

  2010cites this paper
• Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies

  2010cites this paper
• Use of tacrolimus in Chinese renal transplant recipients

  2009cites this paper
• Rapid onset of diabetic nephropathy in three renal allografts despite normoglycemia.

  2009cites this paper
• Review article: New‐onset diabetes after transplantation

  2008cites this paper
• Effects of non-steroid immunosuppressive drugs on insulin secretion in transplantation Effets des immunosuppresseurs non stéroïdiens sur l’insulinosécrétion en transplantation

  2007cites this paper
• Impact of Posttransplant Diabetes Mellitus on Outcome After Transplantation

  2007cites this paper
• Effets des immunosuppresseurs non stéroïdiens sur l'insulinosécrétion en transplantation

  2007cites this paper
• Effects of non-steroid immunosuppressive drugs on insulin secretion in transplantation.

  2007cites this paper
• Calcineurin-based immunosuppression in renal transplantation : focus on efficacy, the role of steroids, and the cardiovascular risk

  2006cites this paper
• Post-transplant Diabetes Mellitus in Renal Transplant Recipients-Experience in Buddhist Tzu Chi General Hospital

  2006cites this paper
• [Diabetes and heart transplantation].

  2006cites this paper
• Diabetes und Herztransplantation

  2006cites this paper
• Post-Transplantation Diabetes Mellitus

  2005cites this paper
• AIRarg and AIRgluc as predictors of insulin secretory reserve.

  2004cites this paper
• Islet transplantation as a treatment for diabetes - a work in progress.

  2004cites this paper
• Pancreas transplantation: indications and consequences.

  2004cites this paper
• Nonimmunologic complications and gene polymorphisms of immunoregulatory cytokines in long-term renal transplants.

  2004cites this paper
• Biodegradable Microsphere‐Loaded Tacrolimus Enhanced the Effect on Mice Islet Allograft and Reduced the Adverse Effect on Insulin Secretion

  2004cites this paper
• Consequences on beta-cell function and reserve after long-term pancreas transplantation.

  2004cites this paper
• Influence of tacrolimus plus mycophenolate mofetil regimens on acute rejection rate and diabetes mellitus development in renal transplant recipients.

  2004cites this paper
• Rosiglitazone treatment of diabetes mellitus after solid organ transplantation.

  2004cites this paper
• New-onset diabetes mellitus in transplant patients: pathogenesis, complications, and management.

  2004cites this paper
• Il rischio cardiovascolare nel paziente con trapianto renale

  2004cites this paper
• Diabetes Mellitus: Classification and Epidemiology

  2004cites this paper
• Cryopreservation of Human Pancreatic Islets

  2002cites this paper
• INHIBITORY EFFECTS OF IMMUNOSUPPRESSIVE DRUGS ON INSULIN SECRETION FROM HIT-T15 CELLS AND WISTAR RAT ISLETS1

  2002cites this paper
• Complications of Post-transplant Diabetes

  2002cites this paper
• Effect of immunosuppressive doses of cyclosporine on pancreatic beta cell function in pigs.

  2002cites this paper
• Novel approaches to cryopreservation of human pancreatic islets.

  2001cites this paper
• Insulin sensitivity and beta-cell secretion after liver transplantation in patients with acute liver failure.

  2001cites this paper
• Impact of cyclosporine and low-dose steroid therapy on insulin sensitivity and beta-cell function in patients with long-term liver grafts

  2001cites this paper
• beta-Cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus.

  2001cites this paper
• [Post-transplantation diabetes mellitus and its association with current immunodepressants].

  2001cites this paper
• Post-transplant diabetes: incidence, relationship to choice of immunosuppressive drugs, and treatment protocol.

  2001cites this paper
• Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years.

  2001cites this paper
• Diabetes mellitus postrasplante y su relación con los inmunodepresores actuales

  2001cites this paper
• Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors.

  2001cites this paper
• Impact of cyclosporine and low‐dose steroid therapy on insulin sensitivity and beta‐cell function in patients with longterm liver grafts

  2001cites this paper
• Risk factors for posttransplant diabetes mellitus and impact of this complication after renal transplantation.

  2000cites this paper
• Regulation of glucose tolerance in patients after liver transplantation: impact of cyclosporin versus tacrolimus therapy.

  2000cites this paper
• Cardiovascular Risk Factors in Renal Transplant Recipients

  2000cites this paper
• Islet cell transplantation for insulin-dependent diabetes mellitus: perspectives from the present and prospects for the future

  2000cites this paper
• Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation.

  1999cites this paper
• Risk for posttransplant Diabetes mellitus with current immunosuppressive medications.

  1999cites this paper
• Diabetic Renal-Retinal Syndrome

  1998cites this paper
• Renal transplantation in a patient with methylmalonic acidaemia

  1998cites this paper
• Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes?

  1998cites this paper
• The effects of maintenance doses of FK506 versus cyclosporin A on glucose and lipid metabolism after orthotopic liver transplantation.

  1998cites this paper
• Caratteristiche, Prevalenza e Fattori Di Rischio Del Diabete Mellito Post-Trapianto Renale

  1998cites this paper
• Islet transplantation.

  1997cites this paper
• Post-Transplant Diabetes Mellitus

  1997cites this paper
• Effects of Immunosuppressive Agents on Glucose Metabolism

  1995cites this paper
• Posttransplant diabetes mellitus--a review.

  1994cites this paper
• Altered body composition and fuel metabolism in stable kidney transplant patients on immuno‐suppressive monotherapy with cyclosporine A

  1994cites this paper
• Diabetogenicity of FK506 versus cyclosporine in liver transplant recipients.

  1994cites this paper
• Altered microcirculation and secretion in transplanted islets.

  1994cites this paper
• Extrarenal effect of cyclosporine A on potassium homeostasis in renal transplant recipients

  1993cites this paper